405 related articles for article (PubMed ID: 15148325)
1. Differential expression of cholesterol hydroxylases in Alzheimer's disease.
Brown J; Theisler C; Silberman S; Magnuson D; Gottardi-Littell N; Lee JM; Yager D; Crowley J; Sambamurti K; Rahman MM; Reiss AB; Eckman CB; Wolozin B
J Biol Chem; 2004 Aug; 279(33):34674-81. PubMed ID: 15148325
[TBL] [Abstract][Full Text] [Related]
2. Increased Levels of 27-Hydroxycholesterol Induced by Dietary Cholesterol in Brain Contribute to Learning and Memory Impairment in Rats.
Zhang X; Lv C; An Y; Liu Q; Rong H; Tao L; Wang Y; Wang Y; Xiao R
Mol Nutr Food Res; 2018 Feb; 62(3):. PubMed ID: 29193679
[TBL] [Abstract][Full Text] [Related]
3. Expression of sterol 27-hydroxylase in glial cells and its regulation by liver X receptor signaling.
Gilardi F; Viviani B; Galmozzi A; Boraso M; Bartesaghi S; Torri A; Caruso D; Crestani M; Marinovich M; de Fabiani E
Neuroscience; 2009 Dec; 164(2):530-40. PubMed ID: 19665519
[TBL] [Abstract][Full Text] [Related]
4. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
Djelti F; Braudeau J; Hudry E; Dhenain M; Varin J; Bièche I; Marquer C; Chali F; Ayciriex S; Auzeil N; Alves S; Langui D; Potier MC; Laprevote O; Vidaud M; Duyckaerts C; Miles R; Aubourg P; Cartier N
Brain; 2015 Aug; 138(Pt 8):2383-98. PubMed ID: 26141492
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease.
Hudry E; Van Dam D; Kulik W; De Deyn PP; Stet FS; Ahouansou O; Benraiss A; Delacourte A; Bougnères P; Aubourg P; Cartier N
Mol Ther; 2010 Jan; 18(1):44-53. PubMed ID: 19654569
[TBL] [Abstract][Full Text] [Related]
6. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux.
Abildayeva K; Jansen PJ; Hirsch-Reinshagen V; Bloks VW; Bakker AH; Ramaekers FC; de Vente J; Groen AK; Wellington CL; Kuipers F; Mulder M
J Biol Chem; 2006 May; 281(18):12799-808. PubMed ID: 16524875
[TBL] [Abstract][Full Text] [Related]
7. Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation.
Testa G; Staurenghi E; Zerbinati C; Gargiulo S; Iuliano L; Giaccone G; Fantò F; Poli G; Leonarduzzi G; Gamba P
Redox Biol; 2016 Dec; 10():24-33. PubMed ID: 27687218
[TBL] [Abstract][Full Text] [Related]
8. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease.
Koldamova RP; Lefterov IM; Staufenbiel M; Wolfe D; Huang S; Glorioso JC; Walter M; Roth MG; Lazo JS
J Biol Chem; 2005 Feb; 280(6):4079-88. PubMed ID: 15557325
[TBL] [Abstract][Full Text] [Related]
9. Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment.
Loera-Valencia R; Goikolea J; Parrado-Fernandez C; Merino-Serrais P; Maioli S
J Steroid Biochem Mol Biol; 2019 Jun; 190():104-114. PubMed ID: 30878503
[TBL] [Abstract][Full Text] [Related]
10. Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells.
Milagre I; Olin M; Nunes MJ; Moutinho M; Lövgren-Sandblom A; Gama MJ; Björkhem I; Rodrigues E
Neurochem Int; 2012 Jan; 60(2):192-8. PubMed ID: 22185844
[TBL] [Abstract][Full Text] [Related]
11. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
[TBL] [Abstract][Full Text] [Related]
12. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion.
Koldamova RP; Lefterov IM; Ikonomovic MD; Skoko J; Lefterov PI; Isanski BA; DeKosky ST; Lazo JS
J Biol Chem; 2003 Apr; 278(15):13244-56. PubMed ID: 12547833
[TBL] [Abstract][Full Text] [Related]
13. The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis.
Hoe HS; Cooper MJ; Burns MP; Lewis PA; van der Brug M; Chakraborty G; Cartagena CM; Pak DT; Cookson MR; Rebeck GW
J Neurosci; 2007 Oct; 27(40):10895-905. PubMed ID: 17913923
[TBL] [Abstract][Full Text] [Related]
14. Reduction of Liver X Receptor β expression in primary rat neurons by antisense oligodeoxynucleotides decreases secreted amyloid β levels.
Wang Q; Wang S; Shi Y; Yao M; Hou L; Jiang L
Neurosci Lett; 2014 Feb; 561():146-50. PubMed ID: 24394905
[TBL] [Abstract][Full Text] [Related]
15. Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse.
Meljon A; Wang Y; Griffiths WJ
Biochem Biophys Res Commun; 2014 Apr; 446(3):768-74. PubMed ID: 24491562
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide.
Nelson TJ; Alkon DL
J Biol Chem; 2005 Feb; 280(8):7377-87. PubMed ID: 15591071
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
[TBL] [Abstract][Full Text] [Related]
18. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
19. On the regulatory importance of 27-hydroxycholesterol in mouse liver.
Heverin M; Ali Z; Olin M; Tillander V; Joibari MM; Makoveichuk E; Leitersdorf E; Warner M; Olivercrona G; Gustafsson JÅ; Björkhem I
J Steroid Biochem Mol Biol; 2017 May; 169():10-21. PubMed ID: 26851362
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population.
Ma SL; Tang NL; Lam LC; Chiu HF
Int Psychogeriatr; 2006 Mar; 18(1):37-45. PubMed ID: 16734927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
